|

Oxaliplatin intravenous Clinical Trials

1 actively recruiting trial

Also known as: Oxaliplatin IV

Pipeline

Phase 3: 1

Top Sponsors

  • Federation Francophone de Cancerologie Digestive1

Indications

  • Liver Disease1
  • Colorectal Neoplasms1
  • Liver Cancer1
  • Cancer1

Other1 trial

Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.